Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Cardiovascular Medicine
Published in: Current Treatment Options in Cardiovascular Medicine 2/2013

01-04-2013 | Vascular Disease (H Gornik and E Kim, Section Editors)

Vascular Access Complications: Diagnosis and Management

Authors: Raghu Kolluri, MD, Brian Fowler, BS, Shailesh Nandish, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 2/2013

Login to get access

Opinion statement

The incidence of vascular access site related complications ranges between 0.8 % to 1.8 % of diagnostic cardiac catheterization and up to 9 % of percutaneous coronary interventions (PCI) [1]. The femoral vessels at the groin are used as the access site for the majority of percutaneous coronary, peripheral arterial and venous, and electrophysiologic interventions. With emergence of endovascular abdominal aortic aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), and transcatheter aortic valve replacement (TAVR), larger access sheaths (up to 18Fr–24Fr) are required, which further increases the potential for access site complications. The true incidence of access site complications arising from non-coronary interventions is unknown; hence it is likely that the total incidence of vascular access site complications is greatly underestimated. Vascular closure devices (VCDs), radial artery access, fluoroscopic guidance, and ultrasound guidance have all been used with a hope to minimize these complications. Despite these attempts, vascular access complications have not been eliminated. Cardiovascular specialists must promptly identify these complications and manage them appropriately.
Literature
1.
Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;153(4):606–11.PubMedCrossRef
2.
Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008;1(3):317–26.PubMedCrossRef
3.••
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654. This is a consensus document for management of peripheral arterial disease. Important document for all practicing cardiovascular documents.PubMedCrossRef
4.
Morgan R, Belli AM. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Intervent Radiol. 2003;14(6):697–710.CrossRef
5.
Coughlin BF, Paushter DM. Peripheral pseudoaneurysms: evaluation with duplex US. Radiology. 1988;168(2):339–42.PubMed
6.
Finkelstein A, Bazan S, Halkin A, Herz I, George J, Miller HI, et al. Treatment of post-catheterization femoral artery pseudo-aneurysm with para-aneurysmal saline injection. Am J Cardiol. 2008;101(10):1418–22.PubMedCrossRef
7.••
La Perna L, Olin JW, Goines D, Childs MB, Ouriel K. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation. 2000;102(19):2391–5. Important document that reported the "3-way stopcock technique".PubMedCrossRef
8.
Webber GW, Jang J, Gustavson S, Olin JW. Contemporary management of postcatheterization pseudoaneurysms. Circulation. 2007;115(20):2666–74.PubMedCrossRef
9.•
Kelm M, Perings SM, Jax T, Lauer T, Schoebel FC, Heintzen MP, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol. 2002;40(2):291–7. Prospective study regarding AV Fistula incidence and natural history.PubMedCrossRef
10.
Onal B, Ilgit ET, Akpek S, Coskun B. Postcatheterization femoral arteriovenous fistula: endovascular treatment with N-butyl-cyanoacrylate embolization. Cardiovasc Intervent Radiol. 2006;29(2):276–8.PubMedCrossRef
11.
Zhou T, Liu ZJ, Zhou SH, Shen XQ, Liu QM, Fang ZF, et al. Treatment of postcatheterization femoral arteriovenous fistulas with simple prolonged bandaging. Chin Med J (Engl). 2007;120(11):952–5.
12.
Stigall KE, Dorsey JS. Late complications of traumatic arteriovenous fistula. Case report and overview. Am Surg. 1989;55(3):180–3.PubMed
13.
Schaub F, Theiss W, Heinz M, Zagel M, Schomig A. New aspects in ultrasound-guided compression repair of postcatheterization femoral artery injuries. Circulation. 1994;90(4):1861–5.PubMedCrossRef
14.
Vaninbroukx I, Vandekerkhof J. Endovascular stent graft treatment for iatrogenic arteriovenous fistulas after femoral catheterisation. Acta Chir Belg. 2004;104(5):584–7.PubMed
15.
Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Interv Radiol. 1996;19(5):323–8.
16.
Thalhammer C, Kirchherr AS, Uhlich F, Waigand J, Gross CM. Postcatheterization pseudoaneurysms and arteriovenous fistulas: repair with percutaneous implantation of endovascular covered stents. Radiology. 2000;214(1):127–31.PubMed
17.
Sovik E, Klow NE, Brekke M, Stavnes S. Elective placement of covered stents in native coronary arteries. Acta Radiol. 2003;44(3):294–301.PubMed
18.
Tsetis DK, Kochiadakis GE, Hatzidakis AA, Skalidis EI, Chryssou EG, Tritou IN, et al. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization. Cardiovasc Intervent Radiol. 2002;25(1):36–41.PubMedCrossRef
19.
Prasad A, Compton PA, Roesle M, Makke L, Rogers S, Banerjee S, et al. Incidence and treatment of arterial access dissections occurring during cardiac catheterization. J Interv Cardiol. 2008;21(1):61–6.PubMedCrossRef
20.
Tsetis D. Endovascular treatment of complications of femoral arterial access. Cardiovasc Intervent Radiol. 2010;33(3):457–68.PubMedCrossRef
21.
22.
Silva JA, White CJ, Quintana H, Collins TJ, Jenkins JS, Ramee SR. Percutaneous revascularization of the common femoral artery for limb ischemia. Cathet Cardiovasc Intervent. 2004;62(2):230–3.CrossRef
23.
Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Cathet Cardiovasc Intervent. 2007;69(7):961–6.CrossRef
24.
Sreeram S, Lumsden AB, Miller JS, Salam AA, Dodson TF, Smith RB. Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication. Am Surg. 1993;59(2):94–8.PubMed
25.
Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–10. discussion 10–3.PubMedCrossRef
26.
Bhatty S, Cooke R, Shetty R, Jovin IS. Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management. Interv Cardiol. 2011;3(4):503–14.CrossRef
27.
Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2006;67(4):541–5.CrossRef
28.
Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2005;65(2):196–202.CrossRef
29.
Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, et al. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC Cardiovasc Interv. 2010;3(8):845–50.PubMedCrossRef
30.
Levine GN, Kern MJ, Berger PB, Brown DL, Klein LW, Kereiakes DJ, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003;139(2):123–36.PubMed
31.
Zahn R, Fromm E, Thoma S, Lotter R, Zander M, Wagner S, et al. Local venous thrombosis after cardiac catheterization. Angiology. 1997;48(1):1–7.PubMedCrossRef
32.
Kolluri R, Pinedo D, Goldstein JA, Goswami NJ, Mishkel G. Deep venous thromboses in association with catheterization. J Am Coll Cardiol. 2008;51(Suppl B)(10):B94–B.
33.
Jang JJ, Kim M, Gray B, Bacharach JM, Olin JW. Claudication secondary to Perclose use after percutaneous procedures. Cathet Cardiovasc Intervent. 2006;67(5):687–95.CrossRef
34.
Boston US, Panneton JM, Hofer JM, Sabater EA, Caplice N, Rowland CM, et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg. 2003;17(1):66–71.PubMedCrossRef
35.
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. A new technique. Acta Radiol Suppl. 2008;434:47–52.CrossRef
36.
Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 2010;3(7):751–8.PubMedCrossRef
Metadata
Title
Vascular Access Complications: Diagnosis and Management
Authors
Raghu Kolluri, MD
Brian Fowler, BS
Shailesh Nandish, MD
Publication date
01-04-2013
Publisher
Current Science Inc.
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 2/2013
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-013-0227-8

Other articles of this Issue 2/2013

Current Treatment Options in Cardiovascular Medicine 2/2013 Go to the issue

Vascular Disease (H Gornik and E Kim, Section Editors)

Management of Asymptomatic Carotid Artery Stenosis

Vascular Disease (H Gornik and E Kim, Section Editors)

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach

Vascular Disease (H Gornik and E Kim, Section Editors)

Management of Pulmonary Embolism: State of the Art Treatment and Emerging Research

Vascular Disease (H Gornik and E Kim, Section Editors)

Novel Anticoagulant Use for Venous Thromboembolism: A 2013 Update

Vascular Disease (H Gornik And E Kim, Section Editors)

The Post-Thrombotic Syndrome: A 2012 Therapeutic Update

Vascular Disease (H Gornik and E Kim, Section Editors)

IgG4-related Disease: 2013 Update